Microscopic imaging pierces the 'black box' of cancer bone metastasis

Microscopic imaging pierces the 'black box' of cancer bone metastasis
The first observation of cancer-induced bone loss by intravital microscopy shows surrounding bone cells in cyan, bone remodeling in white; bone-destroying osteoclasts in yellow, and two colors for cancer cells: green for prostate cancer cell nucleus and red for the cytoplasm. Credit: MD Anderson Cancer Center

Scientists at The University of Texas MD Anderson Cancer Center have engineered a system allowing microscopic monitoring and imaging of cancer that has spread to the bone in mice so they can better understand and develop treatment for bone metastasis in humans.

"Advanced prostate cancer and other cancers metastasize to the bones, causing resistance to therapy and pain for patients, but it's not really clear what makes the so special to prostate cancer progression," said Eleonora Dondossola, Ph.D., instructor in Genitourinary Medical Oncology and lead author of a paper in Science Translational Medicine.

"Bone probably provides cues and an attractive microenvironment for cancer to grow," she notes, but noninvasive microscopy to study the process in detail is hindered by the thickness of the outer bone blocking the view of inner cavity and bone marrow.

"It was a black box. Finally, our model allows us to get inside the bone with intravital multiphoton microscopy and shed some light on these phenomena," she said.

The researchers show how the technique can monitor and capture the dynamics of tumor cell interaction with bone and bone resident cells as they occur over time.

  • A tissue-engineered construct under a mouse's skin develops in about a month into bone with an internal cavity and a thin outer layer that the microscope can "see" through.
  • After and other cells populate the cavity, a cancer cell line is injected.
  • Interactions between malignant cells and are viewed through the multiphoton microscope via a small glass window sewn into the skin above the bone.
A 3D reconstruction of a group of prostate cancer cells implanted into the tissue-engineered bone construct. The cell nuclei are green, the cytoplasm is red, and the surrounding bone is cyan. Credit: E. Dondossola et al., Science Translational Medicine (2018)

Multiphoton microscopy is a fluorescent imaging technique used to image living tissue. The microscopes in the lab of Peter Friedl, M.D., Ph.D., professor of Genitourinary Medical Oncology, can capture up to seven parameters at a time. Friedl is senior author of the study.

The bone construct was developed by a team of scientists at the Centre in Regenerative Medicine, Institute of Health and Biomedical Innovation, Queensland University of Technology, in Brisbane, Australia, led by Dietmar Hutmacher, Ph.D.

Normal bone biology involves a balance between bone-creating cells called osteoblasts, and bone-destroying cells called osteoclasts, Dondossola notes. Cancer tips this balance, altering the equilibrium between these two populations and leading to symptomatic bone remodeling.

The team's microscopy showed concentrated around osteoclasts near the tumor. This phenomenon is a known and painful issue for patients with prostate cancer , and a class of drugs called bisphosphonates is used to relieve this symptom. In the clinic, the effect is known to be palliative, relieving pain but not prolonging survival.

The team's multiphoton microscopy captured this effect. They treated the mice with the bisphosphonate zoledronic acid and found that the drug did not reduce the number of osteoclasts, but slowed their activity, preserving bone. Notably, the treatment had no effect on tumor growth, and this explains why the bone is stabilized but patient survival is not prolonged.

Friedl's lab is using this model to study cancer treatments in mice, including co-clinical work in immunotherapy and radiation. Drugs that free the immune system to attack are often thwarted by resistance factors in the tumor microenvironment, which the team hopes to observe and characterize.

More information: E. Dondossola el al., "Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone," Science Translational Medicine (2018). stm.sciencemag.org/lookup/doi/ … scitranslmed.aao5726

Journal information: Science Translational Medicine
Citation: Microscopic imaging pierces the 'black box' of cancer bone metastasis (2018, August 1) retrieved 13 June 2024 from https://medicalxpress.com/news/2018-08-microscopic-imaging-pierces-black-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A reliable, easy-to-use mouse model for investigating bone metastasis


Feedback to editors